7 125 124 statement of changes in equity for the year ended 31 March 2023 Note Attributable to owners of the Company Non-distributable Distributable Total equity RM’000 Share capital RM’000 Hedging reserves RM’000 Retained earnings RM’000 Company At 1 April 2021 620,025 (8,900) 390,621 1,001,746 Cash flow hedge - 6,317 - 6,317 Total other comprehensive income for the year - 6,317 - 6,317 Profit for the year - - 177,397 177,397 Total comprehensive income for the year - 6,317 177,397 183,714 Distribution to owners of the Company - Dividend to owners of the Company 28 - - (85,178) (85,178) Total transactions with owners of the Company - - (85,178) (85,178) At 31 March/1 April 2022 620,025 (2,583) 482,840 1,100,282 Cash flow hedge - 5,210 - 5,210 Total other comprehensive income for the year - 5,210 - 5,210 Profit for the year - - 171,796 171,796 Total comprehensive income for the year - 5,210 171,796 177,006 Distribution to owners of the Company - Dividend to owners of the Company 28 - - (170,356) (170,356) Total transactions with owners of the Company - - (170,356) (170,356) At 31 March 2023 620,025 2,627 484,280 1,106,932 Note 18.1 Note 18.3 The notes on pages 129 to 222 are an integral part of these financial statements. Statements of CASH FLOWS for the year ended 31 March 2023 Note Group Company 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 Cash flows from operating activities Profit before tax 480,831 321,211 172,618 178,447 Adjustments for: Amortisation of: - intangible assets 6 2,058 1,563 - - Change in fair value of: - biological assets 11 19,220 (20,516) - - - agriculture produce (896) (2,361) - - Depreciation of: - investment properties 5 2,953 3,888 - - - property, plant and equipment 3 203,187 190,420 - 10 - right-of-use assets 4 38,319 34,150 - - Derivative gain (198) (552) - - Dividends from: - liquid investments (22) (76) (21) (73) - subsidiaries - - (176,932) (172,607) Finance costs 64,475 51,721 26,319 26,457 Finance income (7,760) (7,780) (31,749) (39,105) Gain on disposal of property, plant and equipment (4,190) (1,264) - - Gain on disposal of asset held for sale (2,684) - - - Gain on disposal of subsidiary - (3,725) - - Gain on unrealised foreign exchange, net (3,504) (7,568) (1,228) (2,171) Gain on unrealised liquid investment (162) (12) (162) (12) Gain on termination of lease contracts (96) (208) - - Impairment loss on: - advances to suppliers 125 - - - - contract assets 41 134 - - - intangible assets 1,211 - - - - property, plant and equipment 11,738 14 - - - trade and other receivables 6,009 5,104 4,225 - - subsidiary - - 1,432 981 Inventories write-down 460 1,110 - - Property, plant and equipment written off 3 2,866 1,999 - - Share of associates’ profits (1,216) (521) - - Operating profit/(loss) before changes in working capital 812,765 566,731 (5,498) (8,073) Changes in working capital: Biological assets (38,250) 459 - - Inventories (276,376) (30,910) - - Trade and other receivables and other financial assets (87,321) (11,327) (9,567) (29,097) Employee benefits 1,383 (1,154) - - Trade and other payables, including derivatives 215,047 5,463 36,791 (43,884) Contract assets (1,964) (24,593) - - Contract costs 225 2,221 - - Contract liabilities 15,044 (8,765) - - Bills payable 115,722 138,351 - - Cash generated from/(used in) operations 756,275 636,476 21,726 (81,054)
RkJQdWJsaXNoZXIy NTkwNzg=